Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke

Objective: Measurement of plasma levels of protein-conjugated acrolein (PC-Acro) together with IL-6 and CRP can be used to identify silent brain infarction (SBI) with high sensitivity and specificity. The aim of this study was to determine how these biomarkers vary during stroke. Methods: Levels of...

Full description

Bibliographic Details
Main Authors: Madoka Yoshida, Naoki Kato, Takeshi Uemura, Mutsumi Mizoi, Mizuho Nakamura, Ryotaro Saiki, Keisuke Hatano, Kunitomo Sato, Shota Kakizaki, Aya Nakamura, Takuya Ishii, Tohru Terao, Yuichi Murayama, Keiko Kashiwagi, Kazuei Igarashi
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:eNeurologicalSci
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650217300084
_version_ 1818298434002616320
author Madoka Yoshida
Naoki Kato
Takeshi Uemura
Mutsumi Mizoi
Mizuho Nakamura
Ryotaro Saiki
Keisuke Hatano
Kunitomo Sato
Shota Kakizaki
Aya Nakamura
Takuya Ishii
Tohru Terao
Yuichi Murayama
Keiko Kashiwagi
Kazuei Igarashi
author_facet Madoka Yoshida
Naoki Kato
Takeshi Uemura
Mutsumi Mizoi
Mizuho Nakamura
Ryotaro Saiki
Keisuke Hatano
Kunitomo Sato
Shota Kakizaki
Aya Nakamura
Takuya Ishii
Tohru Terao
Yuichi Murayama
Keiko Kashiwagi
Kazuei Igarashi
author_sort Madoka Yoshida
collection DOAJ
description Objective: Measurement of plasma levels of protein-conjugated acrolein (PC-Acro) together with IL-6 and CRP can be used to identify silent brain infarction (SBI) with high sensitivity and specificity. The aim of this study was to determine how these biomarkers vary during stroke. Methods: Levels of PC-Acro, IL-6 and CRP in plasma were measured on day 0, 2, 7 and 14 after the onset of ischemic or hemorrhagic stroke. Results: After the onset of stroke, the level of PC-Acro in plasma was elevated corresponding to the size of stroke. It returned to near control levels by day 2, and remained similar through day 14. The degree of the decrease in PC-Acro on day 2 was greater when the size of brain infarction or hemorrhage was larger. An increase in IL-6 and CRP occurred after the increase in PC-Acro, and it was well correlated with the size of the injury following infarction or hemorrhage. The results suggest that acrolein becomes a trigger for the production of IL-6 and CRP, as previously observed in a mouse model of stroke and in cell culture systems. The increase in IL-6 and CRP was also correlated with poor outcome judging from mRS. Conclusion: The results indicate that the degree of the decrease in PC-Acro and the increase in IL-6 and CRP from day 0 to day 2 was correlated with the size of brain infarction, and the increase in IL-6 and CRP with poor outcome at discharge.
first_indexed 2024-12-13T04:35:16Z
format Article
id doaj.art-292dc0a7216e457ca0fef92d395c77f2
institution Directory Open Access Journal
issn 2405-6502
language English
last_indexed 2024-12-13T04:35:16Z
publishDate 2017-06-01
publisher Elsevier
record_format Article
series eNeurologicalSci
spelling doaj.art-292dc0a7216e457ca0fef92d395c77f22022-12-21T23:59:26ZengElseviereNeurologicalSci2405-65022017-06-017C182410.1016/j.ensci.2017.03.005Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during strokeMadoka Yoshida0Naoki Kato1Takeshi Uemura2Mutsumi Mizoi3Mizuho Nakamura4Ryotaro Saiki5Keisuke Hatano6Kunitomo Sato7Shota Kakizaki8Aya Nakamura9Takuya Ishii10Tohru Terao11Yuichi Murayama12Keiko Kashiwagi13Kazuei Igarashi14Amine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, Atsugi Municipal Hospital, Atsugi, Kanagawa, JapanDepartment of Neurosurgery, The Jikei University School of Medicine, Minato-ku, Tokyo, JapanFaculty of Pharmacy, Chiba Institute of Science, Choshi, Chiba, JapanAmine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Chiba, JapanObjective: Measurement of plasma levels of protein-conjugated acrolein (PC-Acro) together with IL-6 and CRP can be used to identify silent brain infarction (SBI) with high sensitivity and specificity. The aim of this study was to determine how these biomarkers vary during stroke. Methods: Levels of PC-Acro, IL-6 and CRP in plasma were measured on day 0, 2, 7 and 14 after the onset of ischemic or hemorrhagic stroke. Results: After the onset of stroke, the level of PC-Acro in plasma was elevated corresponding to the size of stroke. It returned to near control levels by day 2, and remained similar through day 14. The degree of the decrease in PC-Acro on day 2 was greater when the size of brain infarction or hemorrhage was larger. An increase in IL-6 and CRP occurred after the increase in PC-Acro, and it was well correlated with the size of the injury following infarction or hemorrhage. The results suggest that acrolein becomes a trigger for the production of IL-6 and CRP, as previously observed in a mouse model of stroke and in cell culture systems. The increase in IL-6 and CRP was also correlated with poor outcome judging from mRS. Conclusion: The results indicate that the degree of the decrease in PC-Acro and the increase in IL-6 and CRP from day 0 to day 2 was correlated with the size of brain infarction, and the increase in IL-6 and CRP with poor outcome at discharge.http://www.sciencedirect.com/science/article/pii/S2405650217300084Brain infarctionBrain hemorrhageBiomarkersProtein-conjugated acrolein (PC-Acro)Interleukin-6C-reactive protein
spellingShingle Madoka Yoshida
Naoki Kato
Takeshi Uemura
Mutsumi Mizoi
Mizuho Nakamura
Ryotaro Saiki
Keisuke Hatano
Kunitomo Sato
Shota Kakizaki
Aya Nakamura
Takuya Ishii
Tohru Terao
Yuichi Murayama
Keiko Kashiwagi
Kazuei Igarashi
Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
eNeurologicalSci
Brain infarction
Brain hemorrhage
Biomarkers
Protein-conjugated acrolein (PC-Acro)
Interleukin-6
C-reactive protein
title Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
title_full Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
title_fullStr Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
title_full_unstemmed Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
title_short Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke
title_sort time dependent transition of the levels of protein conjugated acrolein pc acro il 6 and crp in plasma during stroke
topic Brain infarction
Brain hemorrhage
Biomarkers
Protein-conjugated acrolein (PC-Acro)
Interleukin-6
C-reactive protein
url http://www.sciencedirect.com/science/article/pii/S2405650217300084
work_keys_str_mv AT madokayoshida timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT naokikato timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT takeshiuemura timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT mutsumimizoi timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT mizuhonakamura timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT ryotarosaiki timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT keisukehatano timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT kunitomosato timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT shotakakizaki timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT ayanakamura timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT takuyaishii timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT tohruterao timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT yuichimurayama timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT keikokashiwagi timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke
AT kazueiigarashi timedependenttransitionofthelevelsofproteinconjugatedacroleinpcacroil6andcrpinplasmaduringstroke